<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p215" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_215{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_215{left:306px;bottom:30px;}
#t3_215{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_215{left:346px;bottom:30px;}
#t5_215{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_215{left:517px;bottom:30px;}
#t7_215{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_215{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_215{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_215{left:1115px;bottom:27px;letter-spacing:0.23px;}
#tb_215{left:35px;bottom:777px;letter-spacing:0.1px;word-spacing:0.09px;}
#tc_215{left:35px;bottom:759px;letter-spacing:0.1px;word-spacing:0.08px;}
#td_215{left:35px;bottom:739px;word-spacing:0.19px;}
#te_215{left:35px;bottom:720px;letter-spacing:0.09px;word-spacing:0.1px;}
#tf_215{left:35px;bottom:700px;letter-spacing:0.08px;word-spacing:0.1px;}
#tg_215{left:35px;bottom:680px;letter-spacing:0.16px;}
#th_215{left:396px;bottom:680px;}
#ti_215{left:35px;bottom:645px;letter-spacing:0.08px;word-spacing:0.11px;}
#tj_215{left:35px;bottom:625px;letter-spacing:0.14px;word-spacing:0.05px;}
#tk_215{left:35px;bottom:606px;letter-spacing:-0.23px;word-spacing:1.63px;}
#tl_215{left:132px;bottom:606px;letter-spacing:0.16px;}
#tm_215{left:493px;bottom:606px;}
#tn_215{left:35px;bottom:570px;letter-spacing:0.11px;word-spacing:-0.5px;}
#to_215{left:35px;bottom:551px;letter-spacing:0.05px;word-spacing:0.14px;}
#tp_215{left:35px;bottom:531px;letter-spacing:0.03px;word-spacing:0.15px;}
#tq_215{left:35px;bottom:512px;letter-spacing:0.09px;word-spacing:0.1px;}
#tr_215{left:35px;bottom:492px;letter-spacing:0.15px;}
#ts_215{left:548px;bottom:492px;}
#tt_215{left:35px;bottom:457px;letter-spacing:0.06px;word-spacing:0.12px;}
#tu_215{left:35px;bottom:437px;letter-spacing:0.06px;word-spacing:0.12px;}
#tv_215{left:35px;bottom:418px;letter-spacing:0.06px;word-spacing:0.13px;}
#tw_215{left:35px;bottom:398px;letter-spacing:0.21px;word-spacing:-0.03px;}
#tx_215{left:35px;bottom:379px;letter-spacing:0.09px;word-spacing:0.09px;}
#ty_215{left:35px;bottom:359px;letter-spacing:0.16px;}
#tz_215{left:405px;bottom:359px;}
#t10_215{left:35px;bottom:324px;letter-spacing:0.14px;word-spacing:-0.39px;}
#t11_215{left:35px;bottom:304px;letter-spacing:0.05px;word-spacing:0.14px;}
#t12_215{left:35px;bottom:284px;letter-spacing:0.03px;word-spacing:0.15px;}
#t13_215{left:35px;bottom:266px;letter-spacing:0.09px;word-spacing:0.1px;}
#t14_215{left:35px;bottom:247px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t15_215{left:132px;bottom:247px;letter-spacing:0.16px;}
#t16_215{left:493px;bottom:247px;}
#t17_215{left:35px;bottom:210px;letter-spacing:0.09px;word-spacing:0.09px;}
#t18_215{left:35px;bottom:190px;letter-spacing:0.01px;word-spacing:-1.05px;}
#t19_215{left:35px;bottom:172px;letter-spacing:0.07px;word-spacing:0.12px;}
#t1a_215{left:35px;bottom:152px;letter-spacing:0.13px;word-spacing:0.07px;}
#t1b_215{left:35px;bottom:133px;letter-spacing:0.03px;word-spacing:0.16px;}
#t1c_215{left:35px;bottom:113px;letter-spacing:0.16px;}
#t1d_215{left:396px;bottom:113px;}
#t1e_215{left:35px;bottom:78px;letter-spacing:0.03px;word-spacing:0.15px;}
#t1f_215{left:35px;bottom:58px;letter-spacing:0.06px;word-spacing:0.13px;}
#t1g_215{left:618px;bottom:777px;letter-spacing:0.04px;word-spacing:-0.96px;}
#t1h_215{left:618px;bottom:759px;letter-spacing:0.07px;word-spacing:0.12px;}
#t1i_215{left:618px;bottom:739px;letter-spacing:0.16px;}
#t1j_215{left:979px;bottom:739px;}
#t1k_215{left:618px;bottom:702px;letter-spacing:0.06px;word-spacing:0.12px;}
#t1l_215{left:618px;bottom:683px;letter-spacing:0.1px;word-spacing:0.09px;}
#t1m_215{left:618px;bottom:665px;letter-spacing:0.08px;word-spacing:0.11px;}
#t1n_215{left:618px;bottom:645px;letter-spacing:-0.07px;word-spacing:0.25px;}
#t1o_215{left:763px;bottom:645px;letter-spacing:0.16px;}
#t1p_215{left:1123px;bottom:645px;}
#t1q_215{left:618px;bottom:608px;letter-spacing:0.07px;word-spacing:0.12px;}
#t1r_215{left:618px;bottom:589px;letter-spacing:0.07px;word-spacing:0.12px;}
#t1s_215{left:618px;bottom:570px;letter-spacing:0.09px;word-spacing:0.09px;}
#t1t_215{left:618px;bottom:551px;letter-spacing:0.07px;word-spacing:0.11px;}
#t1u_215{left:618px;bottom:531px;letter-spacing:0.16px;}
#t1v_215{left:979px;bottom:531px;}
#t1w_215{left:618px;bottom:495px;letter-spacing:0.02px;word-spacing:0.17px;}
#t1x_215{left:618px;bottom:476px;letter-spacing:-0.01px;word-spacing:-1.03px;}
#t1y_215{left:618px;bottom:457px;letter-spacing:0.11px;word-spacing:0.08px;}
#t1z_215{left:618px;bottom:437px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t20_215{left:715px;bottom:437px;letter-spacing:0.16px;}
#t21_215{left:1076px;bottom:437px;}
#t22_215{left:618px;bottom:401px;letter-spacing:0.06px;word-spacing:-1.11px;}
#t23_215{left:618px;bottom:382px;letter-spacing:0.06px;word-spacing:0.13px;}
#t24_215{left:618px;bottom:363px;letter-spacing:0.05px;word-spacing:0.14px;}
#t25_215{left:618px;bottom:343px;letter-spacing:0.09px;word-spacing:0.09px;}
#t26_215{left:618px;bottom:324px;letter-spacing:0.16px;}
#t27_215{left:979px;bottom:324px;}
#t28_215{left:618px;bottom:288px;letter-spacing:0.13px;word-spacing:0.06px;}
#t29_215{left:618px;bottom:269px;letter-spacing:0.05px;word-spacing:0.13px;}
#t2a_215{left:618px;bottom:249px;letter-spacing:0.12px;word-spacing:0.07px;}
#t2b_215{left:618px;bottom:229px;letter-spacing:0.08px;word-spacing:0.1px;}
#t2c_215{left:618px;bottom:210px;letter-spacing:0.16px;}
#t2d_215{left:979px;bottom:210px;}
#t2e_215{left:618px;bottom:174px;letter-spacing:0.02px;word-spacing:0.17px;}
#t2f_215{left:618px;bottom:155px;letter-spacing:0.11px;word-spacing:0.08px;}
#t2g_215{left:618px;bottom:118px;letter-spacing:0.16px;word-spacing:-0.8px;}
#t2h_215{left:618px;bottom:100px;letter-spacing:0.2px;word-spacing:-0.01px;}
#t2i_215{left:618px;bottom:80px;letter-spacing:0.13px;word-spacing:0.06px;}
#t2j_215{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_215{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_215{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_215{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_215{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_215{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_215{font-size:17px;font-family:ArialMT_5tg;color:#005B99;}
.s6_215{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts215" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg215Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg215" style="-webkit-user-select: none;"><object width="1210" height="935" data="215/215.svg" type="image/svg+xml" id="pdf215" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_215" class="t s0_215">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_215" class="t s1_215">© </span>
<span id="t3_215" class="t s0_215">(NCCN </span>
<span id="t4_215" class="t s1_215">© </span>
<span id="t5_215" class="t s0_215">), All rights reserved. NCCN Guidelines </span>
<span id="t6_215" class="t s1_215">® </span>
<span id="t7_215" class="t s0_215">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_215" class="t s2_215">NCCN Guidelines Version 4.2024 </span>
<span id="t9_215" class="t s2_215">Head and Neck Cancers </span>
<span id="ta_215" class="t s3_215">MS-74 </span>
<span id="tb_215" class="t s4_215">177. Bourhis J, Sire C, Graff P, et al. Concomitant chemoradiotherapy </span>
<span id="tc_215" class="t s4_215">versus acceleration of radiotherapy with or without concomitant </span>
<span id="td_215" class="t s4_215">chemotherapy in locally advanced head and neck carcinoma (GORTEC </span>
<span id="te_215" class="t s4_215">99-02): an open-label phase 3 randomised trial. Lancet Oncol </span>
<span id="tf_215" class="t s4_215">2012;13:145-153. Available at: </span>
<span id="tg_215" class="t s5_215">http://www.ncbi.nlm.nih.gov/pubmed/22261362</span><span id="th_215" class="t s4_215">. </span>
<span id="ti_215" class="t s4_215">178. Haigentz M, Jr., Corry J, Strojan P, Ferlito A. Easing acceleration of </span>
<span id="tj_215" class="t s4_215">head and neck chemoradiotherapy. Lancet Oncol 2012;13:113-115. </span>
<span id="tk_215" class="t s4_215">Available at: </span><span id="tl_215" class="t s5_215">http://www.ncbi.nlm.nih.gov/pubmed/22261361</span><span id="tm_215" class="t s4_215">. </span>
<span id="tn_215" class="t s4_215">179. Ang K, Zhang Q, Wheeler RH, et al. A phase III trial (RTOG 0129) of </span>
<span id="to_215" class="t s4_215">two radiation-cisplatin regimens for head and neck carcinomas (HNC): </span>
<span id="tp_215" class="t s4_215">Impact of radiation and cisplatin intensity on outcome [abstract]. J Clin </span>
<span id="tq_215" class="t s4_215">Oncol 2010;28(Suppl 15):Abstract 5507. Available at: </span>
<span id="tr_215" class="t s5_215">http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5507</span><span id="ts_215" class="t s4_215">. </span>
<span id="tt_215" class="t s4_215">180. Nguyen-Tan PF, Zhang Q, Ang KK, et al. Randomized phase III trial </span>
<span id="tu_215" class="t s4_215">to test accelerated versus standard fractionation in combination with </span>
<span id="tv_215" class="t s4_215">concurrent cisplatin for head and neck carcinomas in the Radiation </span>
<span id="tw_215" class="t s4_215">Therapy Oncology Group 0129 trial: long-term report of efficacy and </span>
<span id="tx_215" class="t s4_215">toxicity. J Clin Oncol 2014;32:3858-3866. Available at: </span>
<span id="ty_215" class="t s5_215">https://www.ncbi.nlm.nih.gov/pubmed/25366680</span><span id="tz_215" class="t s4_215">. </span>
<span id="t10_215" class="t s4_215">181. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 French </span>
<span id="t11_215" class="t s4_215">Head and Neck Oncology and Radiotherapy Group randomized trial </span>
<span id="t12_215" class="t s4_215">comparing radiotherapy alone with concomitant radiochemotherapy in </span>
<span id="t13_215" class="t s4_215">advanced-stage oropharynx carcinoma. J Clin Oncol 2004;22:69-76. </span>
<span id="t14_215" class="t s4_215">Available at: </span><span id="t15_215" class="t s5_215">http://www.ncbi.nlm.nih.gov/pubmed/14657228</span><span id="t16_215" class="t s4_215">. </span>
<span id="t17_215" class="t s4_215">182. Denis F, Garaud P, Bardet E, et al. Late toxicity results of the </span>
<span id="t18_215" class="t s4_215">GORTEC 94-01 randomized trial comparing radiotherapy with concomitant </span>
<span id="t19_215" class="t s4_215">radiochemotherapy for advanced-stage oropharynx carcinoma: </span>
<span id="t1a_215" class="t s4_215">comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring </span>
<span id="t1b_215" class="t s4_215">systems. Int J Radiat Oncol Biol Phys 2003;55:93-98. Available at: </span>
<span id="t1c_215" class="t s5_215">http://www.ncbi.nlm.nih.gov/pubmed/12504040</span><span id="t1d_215" class="t s4_215">. </span>
<span id="t1e_215" class="t s4_215">183. Bourhis J, Calais G, Lapeyre M, et al. Concomitant </span>
<span id="t1f_215" class="t s4_215">radiochemotherapy or accelerated radiotherapy: analysis of two </span>
<span id="t1g_215" class="t s4_215">randomized trials of the French Head and Neck Cancer Group (GORTEC). </span>
<span id="t1h_215" class="t s4_215">Semin Oncol 2004;31:822-826. Available at: </span>
<span id="t1i_215" class="t s5_215">http://www.ncbi.nlm.nih.gov/pubmed/15599861</span><span id="t1j_215" class="t s4_215">. </span>
<span id="t1k_215" class="t s4_215">184. Machtay M, Moughan J, Trotti A, et al. Factors associated with </span>
<span id="t1l_215" class="t s4_215">severe late toxicity after concurrent chemoradiation for locally advanced </span>
<span id="t1m_215" class="t s4_215">head and neck cancer: an RTOG analysis. J Clin Oncol 2008;26:3582- </span>
<span id="t1n_215" class="t s4_215">3589. Available at: </span><span id="t1o_215" class="t s5_215">http://www.ncbi.nlm.nih.gov/pubmed/18559875</span><span id="t1p_215" class="t s4_215">. </span>
<span id="t1q_215" class="t s4_215">185. Hartford AC, Palisca MG, Eichler TJ, et al. American Society for </span>
<span id="t1r_215" class="t s4_215">Therapeutic Radiology and Oncology (ASTRO) and American College of </span>
<span id="t1s_215" class="t s4_215">Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation </span>
<span id="t1t_215" class="t s4_215">Therapy (IMRT). Int J Radiat Oncol Biol Phys 2009;73:9-14. Available at: </span>
<span id="t1u_215" class="t s5_215">http://www.ncbi.nlm.nih.gov/pubmed/19100920</span><span id="t1v_215" class="t s4_215">. </span>
<span id="t1w_215" class="t s4_215">186. Holmes T, Das R, Low D, et al. American Society of Radiation </span>
<span id="t1x_215" class="t s4_215">Oncology recommendations for documenting intensity-modulated radiation </span>
<span id="t1y_215" class="t s4_215">therapy treatments. Int J Radiat Oncol Biol Phys 2009;74:1311-1318. </span>
<span id="t1z_215" class="t s4_215">Available at: </span><span id="t20_215" class="t s5_215">http://www.ncbi.nlm.nih.gov/pubmed/19616738</span><span id="t21_215" class="t s4_215">. </span>
<span id="t22_215" class="t s4_215">187. Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity </span>
<span id="t23_215" class="t s4_215">modulated versus conventional radiotherapy in head and neck cancer </span>
<span id="t24_215" class="t s4_215">(PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet </span>
<span id="t25_215" class="t s4_215">Oncol 2011;12:127-136. Available at: </span>
<span id="t26_215" class="t s5_215">http://www.ncbi.nlm.nih.gov/pubmed/21236730</span><span id="t27_215" class="t s4_215">. </span>
<span id="t28_215" class="t s4_215">188. Tribius S, Bergelt C. Intensity-modulated radiotherapy versus </span>
<span id="t29_215" class="t s4_215">conventional and 3D conformal radiotherapy in patients with head and </span>
<span id="t2a_215" class="t s4_215">neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev </span>
<span id="t2b_215" class="t s4_215">2011;37:511-519. Available at: </span>
<span id="t2c_215" class="t s5_215">http://www.ncbi.nlm.nih.gov/pubmed/21324605</span><span id="t2d_215" class="t s4_215">. </span>
<span id="t2e_215" class="t s4_215">189. Ratko TA, Douglas GW, de Souza JA, et al. Radiotherapy </span>
<span id="t2f_215" class="t s4_215">Treatments for Head and Neck Cancer Update. Rockville (MD); 2014. </span>
<span id="t2g_215" class="t s4_215">190. Hunter KU, Schipper M, Feng FY, et al. Toxicities affecting quality of </span>
<span id="t2h_215" class="t s4_215">life after chemo-IMRT of oropharyngeal cancer: prospective study of </span>
<span id="t2i_215" class="t s4_215">patient-reported, observer-rated, and objective outcomes. Int J Radiat </span>
<span id="t2j_215" class="t s6_215">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
